Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Glioma: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Associated Genes | IDH1, IDH2, C3AR1, GBM, GLIOBLASTOMA, CANCER, APOPTOSIS, NEURODEGENERATION |
| Therapeutic Agents | Berberine-inspired Ionizable Lipid, Berberine-Inspired Ionizable Lipid, HDAC inhibitors, Metal complexes (dicyanoargentate-based) |
| KG Connections | 542 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
Glioma["<b>Glioma</b>"]
Als{"Als"}
Glioma -->|"therapeutic_target"| Als
Cancer{"Cancer"}
Glioma -->|"therapeutic_target"| Cancer
Glioblastoma{"Glioblastoma"}
Glioma -->|"associated_with"| Glioblastoma
CANCER(["CANCER"])
CANCER -->|"therapeutic_target"| Glioma
Tumor{"Tumor"}
Tumor -->|"associated_with"| Glioma
GLIOBLASTOMA(["GLIOBLASTOMA"])
GLIOBLASTOMA -->|"associated_with"| Glioma
style Glioma fill:#1a3a4a,stroke:#ef5350,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | therapeutic_target | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Cancer | therapeutic_target | disease | 0.95 |
| Glioblastoma | associated_with | disease | 0.95 |
| Glioblastoma | activates | disease | 0.95 |
| Glioblastoma | therapeutic_target | disease | 0.85 |
| Neurodegeneration | activates | disease | 0.85 |
| Als | associated_with | disease | 0.85 |
| Stress Granules | associated_with | process | 0.80 |
| Autophagy | activates | pathway | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.80 |
| Stem Cell | activates | pathway | 0.80 |
| Cancer | regulates | disease | 0.75 |
| Glioblastoma | regulates | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Stem Cell | therapeutic_target | pathway | 0.70 |
| Tumor Microenvironment | therapeutic_target | pathway | 0.70 |
| Pi3K/Akt | therapeutic_target | pathway | 0.70 |
| Apoptosis | therapeutic_target | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| Chemoresistance | activates | pathway | 0.70 |
| Apoptosis | inhibits | pathway | 0.70 |
| Invasion | regulates | pathway | 0.70 |
| Ferroptosis | activates | pathway | 0.70 |
| Invasion | activates | pathway | 0.70 |
| Differentiation | activates | pathway | 0.70 |
| Mtor | therapeutic_target | pathway | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Aging | treats | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Glutamate Signaling | associated_with | pathway | 0.60 |
| Tumor Microenvironment | associated_with | pathway | 0.60 |
| Drug Resistance | regulates | pathway | 0.60 |
| Epithelial-Mesenchymal Transition | therapeutic_target | pathway | 0.60 |
| Wnt | therapeutic_target | pathway | 0.60 |
| Metastasis | therapeutic_target | pathway | 0.60 |
| Nf-Κb | therapeutic_target | pathway | 0.60 |
| Multidrug Resistance | therapeutic_target | pathway | 0.60 |
| Invasion | associated_with | pathway | 0.60 |
| Pi3K/Akt | inhibits | pathway | 0.60 |
| Immune Response | therapeutic_target | pathway | 0.60 |
| Pyroptosis | therapeutic_target | pathway | 0.60 |
| Necroptosis | therapeutic_target | pathway | 0.60 |
| Apoptosis | regulates | pathway | 0.60 |
| Glycolysis | regulates | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | therapeutic_target | gene | 1.00 |
| Tumor | associated_with | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| GLIOBLASTOMA | associated_with | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| GLIOBLASTOMA | activates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 0.95 |
| LOX | associated_with | gene | 0.92 |
| LOXL1 | associated_with | gene | 0.92 |
| LOXL2 | associated_with | gene | 0.92 |
| LOXL3 | associated_with | gene | 0.92 |
| LOXL4 | associated_with | gene | 0.92 |
| Stress Granules | involved_in | process | 0.90 |
| IDH2 | biomarker_for | gene | 0.90 |
| 1p/19q Codeletion | biomarker_for | biomarker | 0.90 |
| 1P/19Q Codeletion | biomarker_for | biomarker | 0.90 |
| Claudins | promotes | protein | 0.90 |
| GBM | activates | gene | 0.85 |
| EGFR | therapeutic_target | gene | 0.85 |
| GBM | therapeutic_target | gene | 0.85 |
| MCOLN1 | targets | protein | 0.85 |
| GLIOBLASTOMA | therapeutic_target | gene | 0.85 |
| CANCER | regulates | gene | 0.85 |
| AUTOPHAGY | activates | gene | 0.85 |
| GLIOBLASTOMA | regulates | gene | 0.85 |
| APOPTOSIS | activates | gene | 0.85 |
| CANCER | activates | gene | 0.85 |
| LOX | biomarker_for | gene | 0.85 |
| Lox/Loxl Co-Expressed Genes | biomarker_for | biomarker | 0.85 |
| Berberine-Inspired Ionizable Lipid | treats | compound | 0.85 |
| Senescence Associated Secretory Phenotype | associated_with | phenotype | 0.80 |
| B-series Gangliosides | associated_with | compound | 0.80 |
| GSDM Family | biomarker_for | protein | 0.80 |
| RPL39 | biomarker_for | gene | 0.80 |
| Senescence | contributes_to | process | 0.80 |
| Berberine-inspired Ionizable Lipid | treats | compound | 0.80 |
| LOX/LOXL | targets | enzyme | 0.80 |
| PIEZO1 | involved_in | protein | 0.80 |
| Mutation-Specific Antibodies | biomarker_for | biomarker | 0.80 |
| HDAC inhibitors | treats | drug | 0.80 |
| Piezo1 | implicated_in | protein | 0.80 |
| Metal complexes (dicyanoargentate-based) | treats | compound | 0.80 |
| CLDN1 | downregulates | gene | 0.80 |
| CLDN5 | downregulates | gene | 0.80 |
| BRAF | therapeutic_target | gene | 0.75 |
| AKT | therapeutic_target | gene | 0.75 |
| MTOR | therapeutic_target | gene | 0.75 |
| PI3K | therapeutic_target | gene | 0.75 |
| APOPTOSIS | therapeutic_target | gene | 0.75 |
| PI3K | activates | gene | 0.75 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 0 hypotheses
neuro-oncology | 2026-04-13 | 0 hypotheses
neurodegeneration | 2026-04-13 | 0 hypotheses
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||